ITGAV and cancer: The experimental results demonstrated that the migration ability of the cell lines with the overexpression of ITGAV was significantly enhanced, whereas the knockdown of ITGAV significantly suppressed cell migration and motility, indicating the pivotal role of ITGAV in promoting the cancer cell migration movement in PAAD and LIHC.